Ortivus AB (publ) (STO:ORTI.B)
Sweden · Delayed Price · Currency is SEK 1.480
-0.020 (-1.33%)
Mar 4, 2026, 1:47 PM CET
Ortivus AB Market Cap
Ortivus AB has a market cap or net worth of 132.01 million as of March 4, 2026. Its market cap has increased by 54.46% in one year.
Market Cap
132.01M
Enterprise Value
142.65M
Revenue
73.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.48
Market Cap Chart
Since March 2, 1998, Ortivus AB's market cap has decreased from 1.69B to 132.01M, a decrease of -92.17%. That is a compound annual growth rate of -8.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 133.77M | 24.08% |
| Dec 30, 2025 | 107.81M | 66.21% |
| Dec 30, 2024 | 64.86M | -60.95% |
| Dec 29, 2023 | 166.09M | -32.54% |
| Dec 30, 2022 | 246.21M | 6.08% |
| Dec 30, 2021 | 232.10M | 1.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 136.67B |
| Getinge AB | 55.26B |
| Sectra AB | 37.34B |
| Medicover AB | 32.84B |
| NextCell Pharma AB | 157.06M |
| Immunovia AB | 146.31M |
| IRLAB Therapeutics AB | 145.92M |
| Active Biotech AB | 144.72M |